Pharmacokinetics of levamisole in cancer patients treated with 5- fluorouracil

Cancer Chemotherapy and Pharmacology

Volumn 45, Issue 3, 2000, Pages 247-251

  Gwilt, Peter ^a   Tempero, Margaret ^b   Kremer, Alton ^c   Connolly, Mary ^c   Ding, Cliff ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Dick Holland Regenerative Medicine Program   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

5 Fluorouracil; Cancer; Colorectal; Levamisole; Pharmacokinetics

Indexed keywords

DRUG METABOLITE; FLUOROURACIL; LEVAMISOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0033963048     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050036     Document Type: Article

References (20)

1. 1. Adams JG (1978) Pharmacokinetics of levamisole. J Rheumatol 5: 137
2. 2. Becker RA, Cleveland WS (1996) S-PLUS Trellis Graphics User's Manual. MathSoft, Bell Laboratories, Murray Hill
3. 3. Cleary JF, Arzoomanian R, Alberti D, Feierabend C, Storer B, Witt P, Carbone P, Widing G (1997) A phase I study of 5-fluorouracil, leucovorin and levamisole. Cancer Chemother Pharmacol 39: 300
4. 4. Grasela TH, Sheiner LB (1991) Pharmacostatistical modeling for observational data. J Pharmacokinet Biopharm 19: 25 S
5. 5. Graziani G, De Martini GL (1977) Pharmacokinetic studies of levamisole: on the pharmacokinetics and bioavailability of levamisole in man. Drugs Exp Clin Res 2: 235
6. 6. Kouassi E, Caille G, Lery L, Lariviere L, Vezina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7: 71
7. 7. Kovach JS, Svingen P, McGovern R (1990) Levamisole preferentially potentiates the antiproliferative activity of 5-fluorouracil compared to 5-fluoro-2′ deoxyuridine in vitro. Proc Am Assoc Cancer Res 31: 399
8. 8. Laurie JA, Moertel CG Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Malliard J, Twito DI, Morton RF, Tschetter LK, Barlow JF (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7: 1447
9. 9. Luyckx M, Rousseau F, Cazin M, Brunet C, Cazin JC, Haguenoer JM, Devulder B, Lesieur I, Lesieur D, Gosselin P, Adenis L, Cappelaere P, Demaille A (1982) Pharmacokinetics of levamisole in healthy subjects and cancer patients. Eur Drug Metab Pharmacokinet 7: 247
10. 10. Macdonald JS, Haller D (1997) Update on adjuvant therapy of colon cancer. Tumori 83: S39
11. 11. McNeil JJ, Krum H (1996) Cardiovascular Disorders. In: Speight TM, Holford NHG (eds) Avery's drug treatment, 4th edn. Adis International, Auckland, p 809
12. 12. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Maillard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352
13. 13. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444
14. 14. NONMEM Project Group (1998) NONMEM, Version V, Level 2. University of California at San Francisco
15. 14C-levamisole in the lactating cow. Xenobiotica 26: 863
16. 16. Reid J, Kovach JS, O'Connell MJ, Bagniewski PG, Moertel CG (1998) Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer. Cancer Chemother Pharmacol 41: 477
17. 17. Sheiner LB, Beale SL (1981) Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9: 503
18. 18. Welling PG (1984) Effects of gastrointestinal disease on drug absorption. In: Benet LZ, Massoud N, Gambertoglio JG (eds) Pharmacokinetic basis for drug treatment. Raven Press, New York, p 29
19. 19. Woestenborghs R, Michielsen L, Heykants J (1981) Determination of levamisole in plasma and animal tissue by gas chromatography with thermionic specific detection. J Chromatogr 224: 25
20. 20. Zorsky PE, Perkins JB (1993) Optimizing high-dose chemotherapy using pharmacokinetic principles. Semin Oncol 20: 2